[go: up one dir, main page]

SE0102380D0 - Kräm för behandling av åldersförändringar i huden hos människa - Google Patents

Kräm för behandling av åldersförändringar i huden hos människa

Info

Publication number
SE0102380D0
SE0102380D0 SE0102380A SE0102380A SE0102380D0 SE 0102380 D0 SE0102380 D0 SE 0102380D0 SE 0102380 A SE0102380 A SE 0102380A SE 0102380 A SE0102380 A SE 0102380A SE 0102380 D0 SE0102380 D0 SE 0102380D0
Authority
SE
Sweden
Prior art keywords
cream
weight
treatment
man
skin
Prior art date
Application number
SE0102380A
Other languages
English (en)
Swedish (sv)
Inventor
Johan Andersson
Ulf Starlander
Bjoern Andersson
Original Assignee
Macronova Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Macronova Ab filed Critical Macronova Ab
Priority to SE0102380A priority Critical patent/SE0102380D0/xx
Publication of SE0102380D0 publication Critical patent/SE0102380D0/xx
Priority to CN028131169A priority patent/CN1713888B/zh
Priority to ES02747792T priority patent/ES2280554T3/es
Priority to PCT/SE2002/001308 priority patent/WO2003037291A1/fr
Priority to AU2002318699A priority patent/AU2002318699B2/en
Priority to MXPA03011509A priority patent/MXPA03011509A/es
Priority to NZ530226A priority patent/NZ530226A/en
Priority to CA002450726A priority patent/CA2450726A1/fr
Priority to RU2003137600/15A priority patent/RU2313333C2/ru
Priority to KR1020037017319A priority patent/KR100885347B1/ko
Priority to PT02747792T priority patent/PT1411889E/pt
Priority to AT02747792T priority patent/ATE349998T1/de
Priority to EP02747792A priority patent/EP1411889B1/fr
Priority to BR0210760-0A priority patent/BR0210760A/pt
Priority to JP2003539635A priority patent/JP2005507406A/ja
Priority to DE60217356T priority patent/DE60217356T2/de
Priority to DK02747792T priority patent/DK1411889T3/da
Priority to NO20035715A priority patent/NO20035715D0/no
Priority to US10/482,694 priority patent/US20050152856A2/en
Priority to US11/642,948 priority patent/US20070212431A1/en
Priority to CY20071100415T priority patent/CY1107600T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
SE0102380A 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa SE0102380D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa
DK02747792T DK1411889T3 (da) 2001-07-02 2002-06-30 Creme til behandling af hud, som er skadet af solen
RU2003137600/15A RU2313333C2 (ru) 2001-07-02 2002-06-30 Крем для лечения кожи, поврежденной солнцем
PT02747792T PT1411889E (pt) 2001-07-02 2002-06-30 Creme para o tratamento de pele danificada pelo sol
PCT/SE2002/001308 WO2003037291A1 (fr) 2001-07-02 2002-06-30 Creme de soin pour les peaux endommagees par le soleil
AU2002318699A AU2002318699B2 (en) 2001-07-02 2002-06-30 Cream for treatment of skin injured by the sun
MXPA03011509A MXPA03011509A (es) 2001-07-02 2002-06-30 Crema para tratamiento de piel lesionada por el sol.
NZ530226A NZ530226A (en) 2001-07-02 2002-06-30 Cream comprising D, L-alpha-lipoic acid, coenzyme Q-10 and acetyl-L-carnitine hydrochloride for the treatment of sun injured skin
CA002450726A CA2450726A1 (fr) 2001-07-02 2002-06-30 Creme de soin pour les peaux endommagees par le soleil
CN028131169A CN1713888B (zh) 2001-07-02 2002-06-30 用于治疗被太阳损伤的皮肤的膏霜
KR1020037017319A KR100885347B1 (ko) 2001-07-02 2002-06-30 햇빛에 의해 손상된 피부를 치료하기 위한 크림
ES02747792T ES2280554T3 (es) 2001-07-02 2002-06-30 Crema para el tratamiento de la piel dañada por el sol.
AT02747792T ATE349998T1 (de) 2001-07-02 2002-06-30 Creme zur behandlung von sonnengeschädigter haut
EP02747792A EP1411889B1 (fr) 2001-07-02 2002-06-30 Creme de soin pour les peaux endommagees par le soleil
BR0210760-0A BR0210760A (pt) 2001-07-02 2002-06-30 Creme facial para tratamento tópico de pele fotodanificada, e, método para preparar um creme
JP2003539635A JP2005507406A (ja) 2001-07-02 2002-06-30 日光によって損傷を受けた皮膚の治療用クリーム
DE60217356T DE60217356T2 (de) 2001-07-02 2002-06-30 Creme zur behandlung von sonnengeschädigter haut
NO20035715A NO20035715D0 (no) 2001-07-02 2003-12-19 Krem til behandling av solskadet hud
US10/482,694 US20050152856A2 (en) 2001-07-02 2004-06-21 Cream for treatment of skin injured by the sun
US11/642,948 US20070212431A1 (en) 2001-07-02 2006-12-21 Cream for treatment of skin injured by the sun
CY20071100415T CY1107600T1 (el) 2001-07-02 2007-03-26 Κρεμα για τη θepαπεια δερματος τραυματισμενου απο τον ηλιο

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa

Publications (1)

Publication Number Publication Date
SE0102380D0 true SE0102380D0 (sv) 2001-07-02

Family

ID=20284723

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102380A SE0102380D0 (sv) 2001-07-02 2001-07-02 Kräm för behandling av åldersförändringar i huden hos människa

Country Status (20)

Country Link
US (2) US20050152856A2 (fr)
EP (1) EP1411889B1 (fr)
JP (1) JP2005507406A (fr)
KR (1) KR100885347B1 (fr)
CN (1) CN1713888B (fr)
AT (1) ATE349998T1 (fr)
AU (1) AU2002318699B2 (fr)
BR (1) BR0210760A (fr)
CA (1) CA2450726A1 (fr)
CY (1) CY1107600T1 (fr)
DE (1) DE60217356T2 (fr)
DK (1) DK1411889T3 (fr)
ES (1) ES2280554T3 (fr)
MX (1) MXPA03011509A (fr)
NO (1) NO20035715D0 (fr)
NZ (1) NZ530226A (fr)
PT (1) PT1411889E (fr)
RU (1) RU2313333C2 (fr)
SE (1) SE0102380D0 (fr)
WO (1) WO2003037291A1 (fr)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2858932B1 (fr) * 2003-08-22 2009-10-30 Oreal Composition destinee a lutter contre la degradation des fibres de collagene induite en condition d'exposition solaire naturelle
EP1718283B1 (fr) 2004-01-22 2013-03-06 University of Miami Formulations topiques de coenzyme q10 et procedes d'utilisation
US7776915B2 (en) * 2005-03-24 2010-08-17 Tracie Martyn International, Llc Topical formulations and methods of use
CN1723881A (zh) * 2005-06-23 2006-01-25 马开龙 含辅酶q10的治疗皮肤病的组合物及其制备方法
US8454945B2 (en) 2007-03-22 2013-06-04 Berg Pharma Llc Topical formulations having enhanced bioavailability
US7999040B2 (en) * 2007-09-25 2011-08-16 Nanochem Solutions, Inc. Method of making graft copolymers from sodium poly(aspartate) and the resulting graft copolymer
CN102046178B (zh) * 2008-04-01 2013-05-08 安蒂博汀医药公司 用于皮肤护理的组合物和方法
WO2009126764A1 (fr) 2008-04-11 2009-10-15 Cytotech Labs, Llc Procédés et utilisation d'induction de l'apoptose dans des cellules cancéreuses
KR101553074B1 (ko) 2008-07-17 2015-09-14 가천대학교 산학협력단 나노에멀젼 조성물
CN102482713B (zh) 2009-05-11 2017-06-30 博格有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂诊断肿瘤障碍的方法
ES2664793T3 (es) 2010-03-12 2018-04-23 Berg Llc Formulaciones intravenosas de coenzima Q10 (CoQ10) y métodos de uso de las mismas
WO2012138765A1 (fr) 2011-04-04 2012-10-11 Berg Pharma Llc Méthodes de traitement de tumeurs du système nerveux central
MX351781B (es) 2011-06-17 2017-10-30 Berg Llc Composiciones farmaceuticas inhalables.
EA032775B1 (ru) 2013-04-08 2019-07-31 Берг Ллк Способы лечения злокачественной опухоли с использованием комбинированной терапии с коферментом q10
EP3041496B1 (fr) 2013-09-04 2020-04-29 Berg LLC Procédés de traitement du cancer par perfusion continue de coenzyme q10
US20170189350A1 (en) 2015-11-16 2017-07-06 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10
SE543528C2 (en) * 2019-04-04 2021-03-16 Medica Clinical Nord Sverige Ab Cream for treatment of skin injured by the sun
WO2020201377A1 (fr) 2019-04-04 2020-10-08 Medica Clinical Nord Sverige Ab Crème pour le traitement de la peau lésée par le soleil
CN119950732A (zh) * 2023-11-09 2025-05-09 福州大学 一种纳米药物透皮递送系统及其制备方法和应用

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62175415A (ja) * 1986-01-27 1987-08-01 Kanebo Ltd 皮膚化粧料
JP2794433B2 (ja) * 1989-02-02 1998-09-03 丸善製薬株式会社 甘草疎水性フラボノイド製剤
DE4410238A1 (de) * 1994-03-25 1995-09-28 Beiersdorf Ag Hautpflegemittel
RU2116778C1 (ru) * 1995-03-03 1998-08-10 Сергей Сергеевич Автушенко Косметическая композиция
AU6482596A (en) * 1995-07-03 1997-02-05 Wilson T. Crandall Transdermal and oral treatment of androgenic alopecia
DE19537027A1 (de) * 1995-10-05 1997-04-10 Beiersdorf Ag Hautpflegemittel für alte Haut
US5667791A (en) 1996-05-31 1997-09-16 Thione International, Inc. X-ray induced skin damage protective composition
US5977162A (en) * 1996-09-16 1999-11-02 Seidman; Michael D. Therapeutic treatment for auditory function
US6015548A (en) * 1998-07-10 2000-01-18 Shaklee Corporation High efficiency skin protection formulation with sunscreen agents and antioxidants
DE19806947A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Kosmetische oder dermatologische Wirkstoffkombinationen aus mindestens einer Substanz gewählt aus der Gruppe, bestehend aus Carnitin und den Acylcarnitinen, und mindestens einem Chinon und oder mindestens einem Hydrochinon sowie Zubereitungen mit einem Gehalt an solchen Wirkstoffkombinationen
DE19806889A1 (de) * 1998-02-19 1999-08-26 Beiersdorf Ag Verwendung von Acyl-Carnitin
US6013270A (en) * 1998-04-20 2000-01-11 The Procter & Gamble Company Skin care kit
JP2002512944A (ja) * 1998-04-24 2002-05-08 ザ、プロクター、エンド、ギャンブル、カンパニー スキンケア活性剤が沈着する皮膚及び／又は毛髪のための洗浄剤物品
JP2000063273A (ja) * 1998-08-20 2000-02-29 Noevir Co Ltd 免疫機能低下抑制剤
IT1302307B1 (it) * 1998-09-01 2000-09-05 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed atta a migliorarel'utilizzazione metabolica del glucosio, comprendente acetil
US6048886A (en) 1998-10-05 2000-04-11 Neigut; Stanley Compositions and delivery systems for the topical treatment of psoriasis and other conditions of the skin
PL190755B1 (pl) * 1999-01-07 2006-01-31 Pharmena Sp Z Oo Preparat do leczenia i profilaktyki chorób skóry
IT1312377B1 (it) * 1999-03-05 2002-04-15 Uni Ci S R L Composizioni a base di acido tiottico, cisteina e/o n-acetil cisteinada utilizzarsi in preparazioni farmaceutiche, dietetiche e cosmetiche
US6573299B1 (en) * 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
US20020044913A1 (en) 2000-02-11 2002-04-18 Hamilton Nathan D. Cosmetics to support skin metabolism
DE10020874A1 (de) * 2000-04-28 2001-05-17 Murnauer Markenvertrieb Gmbh Kosmetisch-pharmazeutisches Kombinationspräparat
AU2001270554A1 (en) * 2000-06-06 2001-12-17 Basf Aktiengesellschaft Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals
DE10036798A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Mittel zur Behandlung der Haare und der Kopfhaut
DE10036797A1 (de) * 2000-07-28 2002-02-07 Beiersdorf Ag Verwendung von Kombinationen mit einem Gehalt an Carnitinen
DE10059584A1 (de) * 2000-11-30 2002-06-06 Beiersdorf Ag Kosmetische oder dermatologische getränkte Tücher
US20020119114A1 (en) * 2000-12-18 2002-08-29 Beiersdorf Aktiengesellschaft Active ingredient combinations of surface-active citric esters and alpha-lipoic acid, and cosmetic and dermatological preparations containing such mixtures
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
DE10111048A1 (de) * 2001-03-06 2002-09-12 Beiersdorf Ag Verwendung von alpha-Liponsäure zur Herstellung kosmetischer oder dermatologischer Zubereitungen zur Regeneration beanspruchter Haut, insbesondere der gealterten Haut
US20030167556A1 (en) * 2002-03-05 2003-09-11 Consumers Choice Systems, Inc. Methods and devices for transdermal delivery of anti-aging compounds for treatment and prevention of facial or neck skin aging

Also Published As

Publication number Publication date
MXPA03011509A (es) 2004-10-28
DE60217356T2 (de) 2007-10-11
KR100885347B1 (ko) 2009-02-26
NO20035715D0 (no) 2003-12-19
RU2313333C2 (ru) 2007-12-27
DK1411889T3 (da) 2007-05-07
WO2003037291A8 (fr) 2004-05-13
US20040219114A1 (en) 2004-11-04
KR20040030728A (ko) 2004-04-09
US20050152856A2 (en) 2005-07-14
DE60217356D1 (de) 2007-02-15
CY1107600T1 (el) 2013-03-13
US20070212431A1 (en) 2007-09-13
CA2450726A1 (fr) 2003-05-08
WO2003037291A1 (fr) 2003-05-08
CN1713888A (zh) 2005-12-28
EP1411889A1 (fr) 2004-04-28
CN1713888B (zh) 2011-01-26
AU2002318699B2 (en) 2007-01-04
ATE349998T1 (de) 2007-01-15
BR0210760A (pt) 2004-07-20
NZ530226A (en) 2005-08-26
PT1411889E (pt) 2007-04-30
ES2280554T3 (es) 2007-09-16
JP2005507406A (ja) 2005-03-17
RU2003137600A (ru) 2005-03-27
EP1411889B1 (fr) 2007-01-03

Similar Documents

Publication Publication Date Title
CY1107600T1 (el) Κρεμα για τη θepαπεια δερματος τραυματισμενου απο τον ηλιο
MY137060A (en) Topical pharmaceutical compositions comprising proanthocyanidins, glycyrrhetinic acid and telmesteine for the treatment of dermatitis
BR0108452A (pt) Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva
WO2006131737A3 (fr) Methode et composition de traitement de troubles inflammatoires
WO2002085897A8 (fr) Composes heterocycliques pour des complications vasculaires diabetiques et liees au vieillissement
ATE374026T1 (de) Rho-kinase-inhibitoren für die vorbeugung oder behandlung von interstitieller pneumonie und pulmonaler fibrose
NO20070295L (no) Nye CIS-imidazoliner
MXPA05011223A (es) Compuestos de (piperidiniloxi)fenilo, (piperidiniloxi)piridinilo, (piperidinilsulfanil)fenilo y (piperidinilsulfanil)piridinilo como agonistas 5-htif.
WO2001045679A3 (fr) Utilisation d'agents chimiotherapeutiques
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
ATE533765T1 (de) Pyrroloä2,3-cüpyridinderivate und verfahren für deren herstellung
EP1208092A4 (fr) Derive sulfonamide utilise en tant qu'inhibiteur de metalloproteinase matricielle
DE60314722D1 (de) Zusammensetzung für die pharmazeutische oder dietätische verwendung zur bekämpfung von haarausfall
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
DE60214569D1 (de) Harnstoffverbindungen mit antiproteolytischer wirkung
TW200510352A (en) Cycloalkyl substituted amino acid derivatives, processes for their freparation and their use as pharmaceuticals
SE9904765D0 (sv) Pharmaceutically-useful compounds
TW200510308A (en) Isophthalic acid derivatives
ITRM20010445A1 (it) Alfa-chetoglutarati di principi attivi e composizioni che li contengono.
WO2004069781A3 (fr) Derives d'acide 3,5-di-iso-propyl-heptatrienoique a activite de reduction de glucose serique
ATE232725T1 (de) Behandlung der migräne durch verabreichung von alpha-liponsäure oder derivaten derselben
EP1325903A4 (fr) Derives de l'acide 2,3-diphenylpropionique ou leurs sels, medicaments ou inhibiteurs d'adhesion cellulaire en contenant, et leur utilisation
ATE270671T1 (de) Zwischenprodukte für die herstellung von naphthyridin-3-carbonsäure-derivaten
DE60108122D1 (de) Fumarsäuredoppelsalze mit carnitin und einer aminosäure und nahrungs- und lebensmittelzusätze und medikamente die diese enthalten
ATE150019T1 (de) Beta-mercapto-propanamidderivate verwendbar zur behandlung kardiovaskularer krankheiten oder erkrankungen